ArticleAnnals of clinical and translational neurology2026
Deep Learning-Assisted Differentiation of Four Peripheral Neuropathies Using Corneal Confocal Microscopy.
Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bridging gaps in diabetic neuropathy care: A Delphi-based regional consensus from the Gulf Cooperation Council.Journal of diabetes investigation · 2026Review
- Deep Learning-Assisted Differentiation of Four Peripheral Neuropathies Using Corneal Confocal Microscopy.Annals of clinical and translational neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivePeripheral neuropathies contribute to patient disability but may be diagnosed late or missed altogether due to late referral, limitation of current diagnostic methods and lack of specialized testing facilities. To address this clinical gap, we developed NeuropathAI, an interpretable deep learning-based multiclass classification system for rapid, automated diagnosis and differentiation of 88 patients with diabetic peripheral neuropathy (DPN), chemotherapy-induced peripheral neuropathy (CIPN), chronic inflammatory demyelinating polyneuropathy (CIDP), and human immunodeficiency virus-associated sensory neuropathy (HIV-SN).
methodsA deep learning-based multiclass system was developed to analyze corneal nerve images. These images were preprocessed to train and validate the proposed model and the diagnostic utility was evaluated from the accuracy, F1-score and area under the curve to derive sensitivity, specificity and precision.
resultsNeuropathAI achieved excellent results: AUC-96.75%, sensitivity-83.87%, specificity-95.07%, and demonstrated excellent discrimination for CIDP, CIPN, HIV-SN and DPN with one-vs-all AUC scores of 97%, 93.1%, 99.7% and 96.9%, respectively. Explainability visualization through heatmaps demonstrated that regions of decision making by the model localized to areas with nerve fiber loss, enhancing interpretability.
interpretationNeuropathAI achieved rapid and accurate diagnosis of four of the most prevalent peripheral neuropathies globally, underscoring the potential of artificial intelligence-driven corneal image analysis for the rapid diagnosis and differentiation of peripheral neuropathies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.